[Transcatheter arterial infusion of adriamycin-lipiodol suspension to patients with metastatic liver tumor].
Adriamycin-Lipiodol suspension was administered to 44 patients with metastatic liver tumor using the transcatheter arterial infusion method. The result revealed 23% in the over all effect (partial response or more) of the therapy which was evaluated by comparing the CT images of the tumor, 47% in the 25% or more of the decrease of the tumor, and 65%, very effective in the decrease of the smaller tumor (less than 50 cm2). Except for a case of hepatic subcapsular hematoma after the infusion of Adriamycin-Lipiodol suspension, minor complications were experienced such as abdominal pain, slight fever, and so on. No serious exacerbation in liver function test and white blood cell count was noted.
Suzuki
Y
Y
Dept. of Radiology, Tenri Hospital, Japan.
Sano
A
A
Hatabu
H
H
Imanaka
K
K
Takahashi
M
M
Sadato
N
N
Tamaki
T
T
Fujiwara
K
K
Miki
Y
Y
Kawakami
K
K
D000328:Adult; D000368:Aged; D004317:Doxorubicin / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005770:Gastrointestinal Neoplasms / Q000473:pathology; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D007459:Iodized Oil / Q000008:administration & dosage*; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000503:physiopathology / Q000556:secondary; D008875:Middle Aged
D007459:Iodized Oil; D004317:Doxorubicin